EuroQuity Blog
News

InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness. The InvestHorizon Accelerator is for selected deep tech companies to facilitate series A funding.

The second call for application is now open!


InvestHorizon - Are you raising an ambitious Series A? Second call for application is now open!
Have you raised at least €250 K in Seed Funding ? Are you raising an ambitious Series A Investment for your  high-tech company? Would you like to validate your business strategy with peers?
 
If the answers are YES, then you should apply now to join the InvestHorizon Accelerator.
InvestHorizon fosters the investment readiness of Europe's ambitious high-tech companies.
 


How does it work – simple steps to follow
 
Each high-tech start-up accepted into the Accelerator goes through the following stages . If you want to be part of the programme (it’s free of charge), check your eligibility here.
 
How to apply?
 
For those of you who missed our recent webinar you can find out more about the application process here "InvestHorizon - How to apply?" or download the programme presentation.
 
With our best wishes for the summer, we very much look forward to hearing from you.


Tuesday, July 30th 2019
EuroQuity is partnering up with the Africarena Tour to present you the best African tech start-ups
According to a survey conducted by Global Tech Media WeeTracker published in January 2019, African start-ups raised $725,6 million in 2018, "a historic increase of 53% in one year". In other words: the African continent is experiencing a boom that is not expected to slow in the near future!

And in this dynamic landscape, the AfricArena Tour will travel across the continent to discover all those promising technological start-ups that will emerge as leaders in the space. Their goal ? Identify the best of Africa for a summit in Cape Town in November to connect these start-ups with international investors and help them scale up.
 
To support them, EuroQuity will be offering to investors, once again this year, to share exclusive footage of this live tour and thus discover African start-ups at the forefront of innovation.
 

The next sessions you will be able to see in replay are :
 
- Kigali 02/05/2019
- San Francisco 07/05/2019
- New York City 13/05/2019
- Paris 16-18/05/2019
- Lagos 06/06/2019
- Abidjan 11/06/2019
- Dakar 13/06/2019
- Casablanca 03/07/2019
- Tunis 05/07/2019
- Cairo 09/07/2019
- Johannesburg 03/09/2019
- Cape Town 11-12/10/2019
 
You want to access this qualified deal flow? Simple : Log in to EuroQuity and find these companies on the AfricArena label.
 
For more information visit https://www.africarena.co.za/# or send an email to baptiste.baudouin@bpifrance.fr


Thursday, July 18th 2019

We selected companies that are ready to showcase their technology and looking for an investment partner. Each project owner will have 8 minutes to introduce the project to you via webcam. Following the pitch, you will be able to ask questions via the chatbox. Please note that this session will be held in English.


EuroQuity Belgium online pitch session: Brussels technology focus - Thursday, July 4 at 5pm CEST
Take a look at the selection:
 
Edtech / Training
A digital tool to help retaining knowledge while training. Experts estimate that less than 10% of what is learned remains and is used in daily life after 6 months… All the investments to improve trainings (blend learning, experiential learning) are useful and interesting. Nevertheless, it remains a major difficulty to ‘trigger’ the participants when they are back in their daily environment. It is a tool that increases, facilitates and strengthens the implementation of new learnings in daily life.
Target: all compagnies or organizations providing training| 200 K€ sought 
 
Cryptocurrency
The first Belgian cryptocurrency trading platform inaugurated by the deputy prime Minister of Belgium. Providing an easy-to-use, secure and trusted solution, this platform has a very promising future considering that we see an increase of 1,5 million users per year in Europe at the moment.
Partners: Worldline and Delta App. 1,800 customers so farSought: 900 K€ of which 570 K€ have just been raised. Rest 330K to subscribe
 

Digitalisation of the car damage process
Digitalisation of car inspection from damage until repair. An app based on the norm defined by the leasers that brings all the transparency at any change of drivers. The system enables the professionals to turn a car inspection into a request for quotes in the repair network of their choice. The benefits? A process streamlined, a reduction of the car immobilization and a significant saving on the repair itself thanks to our quote comparison module. The platform embeds insurers, brokers, drivers, leasers, fleet managers, damage appraisals experts into the platform.
Partnership with Baloise / Test phase with Europcar | 650 K€ sought
 
Music Tech
Music rights holders need to be identified to get paid for the usage of their tracks by the streaming platforms, i.e. The problem: the way ownership data travels throughout the value chain is unreliable. The solution links this data straight to the audio file with its breakthrough technology.
Ongoing discussions with major streaming platforms, tech actors and labels | 500 K€ sought
 
You wish to attend? Please register via this link.

​If you have any question, please contact Christine Margrève (cmargreve@sowalfin.be )
 


Wednesday, July 3rd 2019

The next ESIL pitch session will be held online on July 11th, from 5 to 6 PM CEST. Six European start-up are looking for funding. Is your country the right place for them to grow?


Join the ESIL cross-border e-pitch session on July 11th at 5:00 pm
Our next ESIL online pitch session will be held on July 11th at 5:00 PM CESTSix European start-ups from the following sectors will be represented : fintech, e-learning, marketplace, medtech… Tickets start from 150.000 €  to 2 M €.
Companies are also looking for commercial partners. That would be appreciated if you could help them with connections.
 
 Register here  - Do not hesitate to share to syndicate with your colleagues.
 
__________________ 
MedTech
We are providing innovative technology for efficient removal of DNA from gene therapy products and rapid DNA isolation for more reliable non-invasive early cancer detection and other in vitro diagnostics. 
Technology is IP protected with 2 patent applications. R&D partnership with renowned research institution. Proof of concept successfully shown. Seed phase. | € 0,25M sought - Slovenia

Marketplace / Business Intelligence / Data

We are a peer-to-peer marketplace for private data empowered solutions, that will allow companies to pay users directly for their data or for profile targeted interactions, like showing a text or video, directing to an url, answering direct questions or receiving targeted products/services recommendations. We aim to provide our users an additional revenue stream, while giving companies an alternative to reach their audience that is fully compliant with GDPR and will reducing customer acquisition. 
Partnered with the biggest Portuguese utility | € 0,5M sought – Portugal

Fintech / Business Intelligence
We streamline and automate currency management for SMEs. Monitor live profit & loss per each one currency invoice to be paid, analyse the budget rate, compare with banks' predictions and more. All relevant accounting & trading data in one spot to make decision faster. 
Winner of CEE Capital Markets Awards 2018 in FX / Payments, Top 50. Creative in Business 2018, Startup Brand Competition 2017 | € 0.15M€ sought – Poland

 
E-Learning platform / Business Intelligence
We check the learning needs of the companies through the benefits it brings: a UX experience to make the learning process intuitive and engaging, a learn-share-system to motivate the employees, both intrinsically, through acquiring knowledge and sharing it among communities of practice and also extrinsically, through the earning function.Named in the 4th place on Top20 in the world platform for customer experience by the largest community of elearning professionals in the world.
Revenue of 4k monthly and since 1 year when we launch the product the total revenue is 50K eur | € 0.35 sought – Netherlands (now it is a company based in Romania)
 
A.I. / Baby Care / Medtech 
We produce Priya, a SAAS B2B composed of hardware complete with video, audio and air quality sensors, artificial intelligence in the cloud and a mobile app for data management and alerts to protect babies in the cradle.
Best 20 European ideas Startupbootcamp - Exhibitor at BLAST 2017 - Best 5 Startup at Edison Pulse -  Finalist Wind StartUp Award -  Finalist of the 2018 AI WorkLab of Luiss EnLabs - Finalist of the 2019 Bioupper Contest - Winner of 5 international design awards - PI Campus, PI School AI Program - Funding 100k Lazio Innova - Global Startup Program ICE  | 0.3M€ sought – Italy

Cyber Security Intelligence / DeepTech
Our company is in cybersecurity Intelligence. Our goal is to ensure the integrity of low-level networks to counter the most recent threats from the internet and in particular from IOTs. Our Artificial Intelligence purpose is to secure in Plug and Plug the internet, and mobile network including 5G and all the IOTs connected to the network. We provide a product that includes hardware and software security in order to deploy 40 Antivirus + 1 Firewall + 1 VPN in Plug & Play.  Simple, intuitive and with a recurrent business model it has been designed to secure the network and make understandable and accessible cybersecurity to all at a glance.
Top 5 in the 100 pitch competition in SLUSH, SOFLAB reward, IOTs Trophy. NDAs and LOIs signed by leading companies as (Thea Laboratories, Allianz, Bouygues ) | 2M€ sought – France




Wednesday, July 3rd 2019
Come to London and learn how to build an angel investor network - ESIL Study Visit

After visiting Milan and Paris, the third edition of the ESIL Study Visits series will be held in London on 9-12 July 2019. UKBAA is hosting this 4 day-expedition in the European Tech Hub which will include a trip to the renowned innovation hub of Cambridge, the birthplace of science-based angel investing in Europe.

This will be a selective meeting for investors interested in discussing how to create an Effective Angel Ecosystem, and what better way to do it than learning from the UK example.

London has been named the top city in the world for foreign direct investment,  it’s known as the ‘Top Tech Hub of the World’, and it is within the Top-3 ecosystems listed in the 2019 Global Startup Ecosystem Ranking.

The programme for the Study Visit is varied and with a range of opportunities, including the chance to visit RocketSpace UKBAA Angel Hub –  Scale-up incubator, part of the Silicon Valley Rocket space programme. As an alternative, and only for the women participating at the event, there will be the option to join UKBAA Women Angel Investing National Forum, where more than 100 women investors will come together to share experiences.

On the morning of Wednesday 11th, attendees will discuss Building a successful ecosystem to support investment in innovation, and see the examples of the new UK £100m Regional Angels Programme Co-Investment Funds launched by British Business Investment  and the Presentation of the new regional Angel Investment Accelerator. In the afternoon, participants will be lucky to visit the Bradfield Centre Cambridge Science Park  and meet with the leading Angel groups in Cambridge, which is the Birthplace of (Science-Based) European Angel Investing. The sudden and rapid rise of Cambridge as an innovation hub has a name: “The Cambridge Phenomenon”.

The Study Visit to the UK will end on July 12th with a workshop on Building and Mobilising Lead angel capacity.

IMPORTANT: Due to limited space, we invite you to submit an application for attendance via the link here. Please do not make travel arrangements yet, as the organisers will assess the applications and then inform you in due time whether you have been selected to attend.

Join Jenny Tooth  (the ESIL Local Leader in the UK) and other #ESILangels  for this exclusive meeting.

For more information about the program, click here.



Tuesday, June 18th 2019
Register to the next European Startup Festival in Malmö in September
In 2017 Adriano Travaglia, a lawyer and entrepreneur, and Christine Michaelis, Marketing and Creative Start-Up Coach, saw that there is something missing in the European Startup Ecosystem. An organisation that is working on a European level from the bottom up – not just on an institutional level, including all the relevant stakeholders such as start-ups, investors, public agencies, cities, accelerators, incubators, event organisers etc.
 
They have founded the European Startup Asssociation and now create a borderless, collaborative European Startup Ecosystem. They celebrate the community with their annual European Startup Festival. To capture the different audiences and stakeholders, the festival is moving around countries across Europe – and so is Christine. This way they get to know the start-up ecosystem in each country much quicker and better and build lasting relationships.
 
The first European Startup Festival in Turin was a big success. This year’s 2-day festival is using a similar programme structure but also adding new thing on. They will have interactive panels on topics like innovation, well-being, marketing and communication, team building, sustainability and funding. In addition to that participants can go to as many masterclasses as they like on specialised topics, run by the expert speakers.

The festival is hosted by a British comedian, has a magician and rapper to ensure that it is not only valuable networking and knowledge transfer but also a lot of fun. An evening reception in the old city hall as well as a party and a walking tour through Malmö ensure further networking opportunities for companies, investors, startups and all other participants.
 
Leading up to the European Startup Festival, they also have 6 Pitching Matches across Europe where start-ups meet investors. These are not public events and can only be participated in by applying as a pitching start-up or judge.
 
The main European Startup Festival is happening in Malmö, Sweden, this year on the 20th and 21st September. Easy flights to Copenhagen will get you there in no time!

Tickets are only 140 Euros including all the panels, masterclasses and the evening reception. Join to expand your network on a European level, learn new things, inspiration and have a lot of fun!

You can get your tickets here.
 


Wednesday, June 12th 2019
Register to the next ESIL e-pitch session featuring Medtech startups, on June 25th at 5:00 PM CEST
Our next ESIL pitch session will be held online on June 25th, from 5 to 6 PM CEST.
Eight companies will be presented. All these Serie A deeptech companies are part of the European Invest Horizon 2020 acceleration program, and are looking for funds to continue their growth.
 
 
Here is the program :

3D Imaging Software for Bone Diagnosis
A medical imaging software development company in four key medical fields: arrhythmias, aneurysm, epilepsy and osteoporosis. They offer the medical technology industry fast and low-cost pathways for the creation of innovative and advanced solutions. They also provide an effective means of bringing these solutions to a growing global market. They achieve this by means of an in-house software development platform for the rapid prototyping of medical imaging applications.
Sales launch in 2018: 6 unites/ € 60K, pipeline > € 300K, CE Mark | € 1.8 M sought

 
Treatment of Localized Adiposity
The company has developed a technology that radically eliminates localized body fat excess (adiposity) and provides results never achieved until now: up to 5 cm. waistline reduction after one 20-minutes session. The company has developed a non-invasive medical device that also uses digital management of ultrasound, shape recognition based on based on IA, augmented reality guidance of the physician. This medical device is being CE marked and should reach the market this year.
The CE marking is in process (electrical tests validated, and technical file being audited). It will be followed by a short test phase in Paris before the beginning of the distribution | 5 M€ sought

 
Digital Health – Data Brooker
The company collects and processes pharmacies commercial data to build up a panel. It’s a data broker as SAAS provider for pharmacies, pharmacy chains, pharmaceutical labs. The data is accessed for their customers through APIs & self-service apps. They only collect commercial data, excluding any « personal » data. Data are extracted hourly from the pharmacy ERP and are only extracted through an explicit agreement and contract with the pharmacy owner. In these General Conditions, the pharmacy owner concedes the right to collect, process and commercialize the data.
They have already deployed the solution on 5,000 point of sales with a steady growth of the panel. | €2.5 M sought

 
Biotech – Neurodegenerative
A biopharmaceutical company dedicated to developing first in class molecules that address important medical needs in the field of neurodegenerative diseases and in the area of deafness.
All data generated from in vitro test methods enable to demonstrate the positive impact of the company on: Induction of neuronal differentiation of murine and human progenitor cells; Protection against toxicity-induced by glutamate and oxidative stress; Stimulation of connections between spiral neuronal ganglion cells and ciliated cells, which are responsible for hearing
Efficacity results from in vivo test methods support that they represent a new class of molecules effective for the purpose of treating patients with neuropathy/synaptopathy linked to hearing loss. | €8 M sought

 
Medical Device – Surgical Instrument for Gynecology
The company aims at serving the gynecology market with a new generation of pain-free single use surgical instrument, to replace the current middle-age painful cervical forceps affecting more than 75 million women every year in routine interventions requiring access to the uterine cavity. The company innovates women's care with new surgical instrument for gentler and more modern gynecological procedures.
12 reference letters from Medical Doctors | €3.5 M sought

 
Medical Device - Virtual Reality Solution
A company specialized in innovative medical devices. They offer healthcare facilities a therapeutic virtual reality solution aimed to alleviate the pain and anxiety of their hospitalized patients. Thanks to a virtual reality headset and a headphone, a patient is transported according to his preferences in rich and lively natural 3D environments like a forest or a mountain. Developed in collaboration with doctors, their virtual experiments are optimized for relaxation and pain distraction through advanced psychological principles such as hypnosis, music therapy or cardiac coherence induction.
They will reach > € 1M orders in 2019 | €2.5 M sought

 
Neurosurgical Platform - Glioblastoma
The company is developing a neurosurgical platform, built around a microrobot to deliver drugs in the brain for targeted therapies. The company as a first application is targeting glioblastoma, a deadly malignant and infiltrative brain cancer with limited survival time (12-16 months).
The technology is currently developed and tested inside hydrogel-based brain models and will be tested on preclinical tests starting in 2020 | €3.5 M sought

 
Biomarkers
The company seeks, develops and qualifies innovative biomarkers for the development of diagnostics in the field of neurological diseases. The purpose of the company is to translate new diagnosis methods for various neurodegenerative diseases into products, and to promote the use of these tests in clinical practice. Their know-how is based on the detection of blood biomarkers.
Currently their biomarker R&D program is dedicated to the clinical qualification of new biomarkers and diagnostic tools for the diagnosis and the follow-up of the Alzheimer’s disease | €2.5 M sought

 


Tuesday, June 11th 2019
The next Belgian e-pitch session will take place on Tuesday 18 June at 5 pm - Register here 

These sessions allow selected companies seeking capital to present their development / growth project. As usual, each manager will have a maximum of 8 minutes to convince you to follow him/her. You will be able to submit your questions online after each pitch.

Here is the selection : 
 
Cleantech - "Smart City through Smart Lighting"
Technology is based on deploying intercommunicating sensors along the streets to adapt, in real-time, street lighting levels to traffic density and type of users: "Light where and when needed". The energy savings are maximal and can reach up to 80%. The solution is also a good entry point for mobility management, a pillar of Smart Cities, opening the way to many applications by feeding information's, in a secure way, to traffic lights, pedestrian crossings, traffic and warning signs.  The infrastructure equipped with additional sensors can transport additional public space information like noise level, air quality, parking occupancy, ...
Partners: Cities and public operators. Deployment on more than 50 sites | Amount sought: €3.0m

 
Medtech
Company develops and markets evidence-based Digital Sedation technology to relieve pain and anxiety without medication in acute care patients.  It realizes these digital therapeutics by combining clinically-proven hypnosis with virtual reality into medical software. The company licenses its digital sedation software based on recurring revenue model, running in a device tuned for use in clinical setting. Over 10,000 patients treated plus 16 clinical studies (>1,600 patients) completed or ongoing, evidencing strong results. Current funding round aiming at international expansion and acceleration continuous R&D innovation.
10,000+ patients, 100+ healthcare centers, 0.4M€ invoiced - 2.8M€ raised to date | 10 M€ sought (staged) 

 
Smart Cities
Company developed an innovative e-commerce marketplace platform and administration mobile apps. The platform creates personalized websites / webshops for local shops and smart cities while the mobile apps allows our customers to manage their shops / events (for cities admin) or products / orders (for shops admin).
App adopted by +15 cities and +10,000 local shops | 2 M€ sought : international growth

 
Digital / Helping SMEs in their digital transformation
New generation digital and secure market network. The model is based on a revaluation of human resources services based on an essential element: the adoption of good practices. By overlaying and with the support of a major Belgian bank, the company recreates its "phygital" ecosystem around the self-employed, thus building the bridges essential to its development, for example: accountants, bankers, social secretariats, professional confederations. Creation of a unique and even monopolistic One-stop-shop at the Belgian level; this model only needs to be duplicated internationally. 
The partners: Belfius Bank, Partena, SD Workx. Several orders in progress. CES las Vegas 2019 | amount requested: : : 1 M€, already secured : 0,7 M€
 
Digital marketing 
The "TripAdvisor" of B2B professional service providers. Digital e-reputation platform to put the customer back in the spotlight. Enable companies to make better purchasing decisions and suppliers to win and retain customers.  Authentication of notifications via a LinkedIn profile to ensure the quality and objectivity of notifications.
Presence in 7 European countries in the next 12 months. Acceleration by the purchasing consulting firm Bridgewater. Project supported by Finance.Brussels | Amount sought: €0.6m

 
Media / MusicTech
Mobile platform that removes barriers between artists and their fans. It allows everyone - regardless of age or musical level - to produce high quality remixes in minutes. Catalogue of 40+ international artists including Roméo Elvis (Be), Le Motel (Be), 20Syl (Hocus Pocus, Fr), Klever (Yelawolf, US), ...
Played by A$AP Rocky in his 2019 tour (US/Asia/US). Used in Adidas' marketing campaigns. More than 1m of downloads worldwide. | Amount requested: €0.8m
 

You wish to attend? You can register now via this link.

​If you have any question, please contact Christine Margrève (cmargreve@sowalfin.be )


Tuesday, June 11th 2019
ESIL Webinars: All events in June
Find the next Webinars offered to investors and Business Angels:
  • Manage investments and follow-on rounds - Wednesday 5th of June at 13:00 CEST
  • Exit Investments - Monday 17th of June at 13:00 CEST
 
Manage investments and follow-on rounds - Wednesday 5th of June at 13:00 CEST

Why should you join this webinar?
Business Angels can take an important role to help the companies they invest in; learn why this is important and some examples. During the investment cycle entrepreneurs will face different challenges and investors can provide some support. Understand what Follow-on rounds are, when you can expect them to happen and the different types. Why do entrepreneurs and investors need these documents? Understand the differences and similaries among Term Sheet, Shareholder Agreement and Statutes. Learn the key components these documents should cover, main clauses and how to create and negotiate them.

What will be covered?
  • How and Why do Angels contribute know-how/support in addition to financing?
  • What are common challenges entrepreneurs face that angels should recognize?
  • When do follow-on rounds usually occur and how do they work?
 
Register: http://events.gobeyondinvesting.com/esil_web_190605
 

ESIL Webinars: All events in June
Exit Investments - Monday 17th of June at 13:00 CEST

Why should you join this webinar?
Finally, the Exit is here! What and when are the investors receiving? Do not forget the tax considerations! Learn what type of Exits might be and what triggers the most common ones. During the Investment Cycle, Exit will be a main topic of discussion, how should you face each stage to increase the chances of success?

What will be covered?
  • How do investors Exit investments?
  • What are the more common types of Exits for Business Angels?
  • Sale of the start-up to a larger company
  • Bankruptcy
  • Repurchase of shares by new investor or founders/startup
  • How does the subject of Exit come up during the life of a startup?
 
Register for this webinar here


Tuesday, June 4th 2019

InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness. The InvestHorizon Accelerator is for selected deep tech companies to facilitate series A funding.

EuroQuity will be there on the 7th, in charge of the first pitch session of the Accelerator programme. 


InvestHorizon kick-off - Discover the second list of top deeptech companies selected in the health sector | Paris, June 7th
The pitching event at a glance:
  • 07th of June from 09:00 to 12:00 CET at Bpifrance's offices 6/8 boulevard Haussmann. 
  • +20 serie A european companies pitching. Two Parallel sessions. 7 min pitch / 5 min Q/A
This invitation is limited to our investment partners (register). Don’t miss out on this great opportunity and save your spot now! 

Here is the first list of deeptech companies:

​___________________________________

Biotech – Transthyretin amyloidosis
A biotech company focused on the design of organ-targeted, high-quality drug candidates for the treatment of life-threatening transthyretin-mediated amyloidosis (ATTR). They work closely with patients and physicians to understand and answer to multiple clinical manifestations of these pathologies which represent unmet medical needs.
The company has succeeded in designing novel and potent TTR stabilizes endowed with physicochemical and pharmacological requirements for the development of two innovative products | €2.5 M sought
 

Digital Health
The company is developing an innovative e-health solution, a web and mobile platform, certified as a medical device, to improve the care of patients whose state of health requires long-term care (chronic, complex).
It allows healthcare professionals, patients and their families to co-define a personalized care plan that is monitored in real time through integrated instant collaboration mechanisms (chat, video). It aims to empower the patient.
They have contracts in France and a strong position in the Canton of Geneva in Switzerland. A pilot is being organized with the Moroccan Ministry of Health | €2.5 M sought
 
 
Biomarkers
The company seeks, develops and qualifies innovative biomarkers for the development of diagnostics in the field of neurological diseases. The purpose of the company is to translate new diagnosis methods for various neurodegenerative diseases into products, and to promote the use of these tests in clinical practice. Their know-how is based on the detection of blood biomarkers.
Currently their biomarker R&D program is dedicated to the clinical qualification of new biomarkers and diagnostic tools for the diagnosis and the follow-up of the Alzheimer’s disease | €2.5 M sought
 

Healthtech – Heart Diseases
The company aims to develop biomedical technology (software and devices) for children with heart diseases. Product line includes patented powerless pediatric asset devices and heart valves already tested in patients. The company also provides blood flow design platforms for cardiovascular surgeons tested in patients. These interactive tools allow surgeons to predict the outcome of their intended operations prior to the actual surgery.
50 surgeons had interest | €500 K sought
 

Arthroscopic Method
In order to solve the problem of superficial cartilage wounds, the company has developed a patented method, that consists to apply a liquid dye that fixes at the surface of the cartilage. It absorbs the light from the laser, enabling to use much less power: even in the absence of the dye, the laser light diffuses without any danger through the articular cartilage. The surgeon will resurface the articular cartilage with the arthroscopic laser. He will withdraw a thin layer of damaged cartilage, leaving a smooth surface. The articulation can then start to function properly.
Instruments and consumables ready for marketing and sales (veterinary market) | €3 M sought
 

Robotic Assisted Rehabilitation
The company is developing and supplying solutions to the emerging market of robotic assisted rehabilitation (RAR) services, using the most advanced technology in their robotic devices, integrating electronics, mechatronics, informatics and telecommunication technologies. They develop a wearable robotic device for knee rehabilitation. It incorporates “assisted as needed” control and functional electrical stimulation (FES) features, helping to speed-up and to improve the rehabilitation process. 
Preliminary contacts to check market acceptance have been carried out with posi6ve results| €1.5 M sought 
  

Medical Device - Neurodegenerative disease
A company that has developed a device, a proprietary medical device to treat motor symptoms of neurological and neurodegenerative conditions. It is effective in treating invalidating mobility problems caused by stroke or Parkinson’s disease. These symptoms do not have adequate response to currently available treatments. Device efficacy has been documented via clinical trials and peer-reviewed publications. Already CE mark and has been accepted by the US FDA in the “Breakthrough Devices Program”, a fast track procedure to expedite patients’ access to innovative medical devices that address unmet medical needs.
400 devices sold mainly in Italy+CH ; CE marked and FDA marketing authorization is expected in mid-2020 | €2.5 M sought
 

Medical Device – Surgical Instrument for Gynecology
The company aims at serving the gynecology market with a new generation of pain-free single use surgical instrument, to replace the current middle-age painful cervical forceps affecting more than 75 million women every year in routine interventions requiring access to the uterine cavity. The company innovates women's care with new surgical instrument for gentler and more modern gynecological procedures.
12 reference letters from Medical Doctors | €3.5 M sought
 

Medical Device - Virtual Reality Solution
A company specialized in innovative medical devices. They offer healthcare facilities a therapeutic virtual reality solution aimed to alleviate the pain and anxiety of their hospitalized patients. Thanks to a virtual reality headset and a headphone, a patient is transported according to his preferences in rich and lively natural 3D environments like a forest or a mountain. Developed in collaboration with doctors, their virtual experiments are optimized for relaxation and pain distraction through advanced psychological principles such as hypnosis, music therapy or cardiac coherence induction.
They will reach > € 1M orders in 2019 | €2.5 M sought


Paradigm of respiratory care
The product of the company is shifting the paradigm of respiratory care in chronic patients. Their proprietary CE-marked device is a mobile ultra-portable spirometer, connected with a smartphone via dedicated apps for patients and physicians. Providing highest, hospital-grade accuracy it has been recognized by leading experts in the field as groundbreaking technology. It allows for full a spirometry examination performed by patient at home as well as in doctors’ office.
CE-marked device | €8 M sought
 
 
Neurosurgical Platform - Glioblastoma
The company is developing a neurosurgical platform, built around a microrobot to deliver drugs in the brain for targeted therapies. The company as a first application is targeting glioblastoma, a deadly malignant and infiltrative brain cancer with limited survival time (12-16 months).
The technology is currently developed and tested inside hydrogel-based brain models and will be tested on preclinical tests starting in 2020 | €3.5 M sought
 

Biomechanics
The company is active ly involved in the fields of physical rehabilitation and sports biomechanics producing precise measuring and training devices for assessment/exercising and follow-up of patients and athletes.
The product is the first centralized solution for functional evaluation and monitoring. It consists of an application and 5 devices to cover almost all the functional work in rehabilitation.
 €360 K turnover; +700 Users | €1.3 M sought
 

Bio-wearables Health
An advanced bio-wearable company currently working on its innovative technology. This technology will allow the analyze of key physiological markers by simply “tasting” the skin rather than analyzing blood samples.
It will enable a precise and continuous monitoring of systemic glucose level anytime and anywhere.
Excellent results in 1st preclinical animal study, > 99% accuracyPreclinical; CE mark expected mid 2022 | €10 M sought
 
 
Healthtech – Holographic 3D solution
A hard-tech company specializing in disruptive holographic 3D solutions from motion video displays to static images. Their technology does not need any head gear where 3D images appear in mid-air, viewable naturally. They have an experienced team delivering on extreme hardware, software and 3D graphics projects. They offer a 3D light-field display capable of showing color motion video, as well as static digital holograms. They can convert any kind of 3D digital data into a hologram. The main applications are in medical imaging, scientific data visualization and engineering design.
Already 43 Medical Professional customers | €2.5 M sought
 

Nanobiotechnology - Cancer Diagnostics
The company has developed a proprietary nanoparticles deposition technology that allows to functionalize any surface providing some unique features in cell biology.
Clinical proof of concept in progress | €5 M sought

 
Physiological diagnostics and therapy
The company has participated in several medical instrument development projects and implemented cardiovascular and pulmonological technologies.
The innovation offers integrated solutions in any of the domains of CVD prevention and early diagnostics, remote care and rehabilitation for many people.
Number of customers approx. 60.000 in Year5 | €2.5 M sought
 


Wednesday, May 29th 2019
1 2 3 4 5 » ... 8
 
Stay informed by suscribing to our newsletter